Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

Gastroenterology

Volumn 134, Issue 2, 2008, Pages 416-423

  Moucari, Rami ^a   Asselah, Tarik ^a   Cazals Hatem, Dominique ^a   Voitot, Hélène ^a   Boyer, Nathalie ^a   Ripault, Marie Pierre ^a   Sobesky, Rodolphe ^a   Martinot Peignoux, Michèle ^a   Maylin, Sarah ^a   Nicolas Chanoine, Marie Hélène ^a   Paradis, Valérie ^a   Vidaud, Michel ^a   Valla, Dominique ^a   Bedossa, Pierre ^a   Marcellin, Patrick ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FATTY LIVER; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 38649120719     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.11.010     Document Type: Article

References (62)

1. Mirandola S., Realdon S., Iqbal J., et al. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 130 (2006) 1661-1669
2. Okuda M., Li K., Beard M.R., et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122 (2002) 366-375
3. Allison M.E., Wreghitt T., Palmer C.R., et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 21 (1994) 1135-1139
4. Mason A.L., Lau J.Y., Hoang N., et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29 (1999) 328-333
5. Caronia S., Taylor K., Pagliaro L., et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30 (1999) 1059-1063
6. Zein N.N., Abdulkarim A.S., Wiesner R.H., et al. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 32 (2000) 209-217
7. Zein C.O., Levy C., Basu A., et al. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 100 (2005) 48-55
8. Mehta S.H., Brancati F.L., Sulkowski S.M., et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133 (2000) 592-599
9. Metha S.H., Brancati F.L., Strathdee S., et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38 (2003) 50-56
10. Lecube A., Hernandez C., Genesca J., et al. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients. Diabetes Care 29 (2006) 1096-1101
11. Hui J.M., Sud A., Farrell G.C., et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 125 (2003) 1695-1704
12. Hickman I.J., Powell E.E., Prins J.B., et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol 39 (2003) 1042-1048
13. Kawaguchi T., Yoshida T., Harada M., et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of cytokine signaling 3. Am J Pathol 165 (2004) 1499-1508
14. Taura N., Ichikawa T., Hamasaki K., et al. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients. Am J Gastroenterol 101 (2006) 1-8
15. Lecube A., Hernandez C., Genesca J., et al. High prevalence of glucose abnormalities in patients with hepatitis C virus infection. Diabetes Care 27 (2004) 1171-1175
16. Heckel R.H., Grundy S.M., and Zimmet P. The metabolic syndrome. Lancet 365 (2005) 1415-1428
17. Alberti K.G., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1061
18. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28 (2005) 2745-2749
19. Petrides A.S., Vogt C., Schulze-Berge D., et al. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 19 (1994) 616-627
20. Fartoux L., Poujol-Robert A., Guechot J., et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 54 (2005) 1003-1008
21. Camma C., Bruno S., Di Marco V., et al. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 43 (2006) 64-71
22. Conjeevaram H.S., Kleiner D.E., Everhart J.E., et al. Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology 45 (2007) 80-87
23. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 1705-1725
24. Dixon J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001) 91-100
25. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123 (2002) 134-140
26. El-Serag H.B., Tran T., and Everhart J.E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126 (2004) 460-468
27. Petit J.M., Bour J.B., Galland-Jos C., et al. Risk for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 35 (2001) 279-283
28. Narita R., Abe S., Kihara Y., et al. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol 41 (2004) 132-138
29. Durante-Mangoni E., Zampino R., Marrone A., et al. Hepatic steatosis and insulin resistance are associated with imbalance of adiponectin/tumor necrosis factor-α in chronic hepatitis C patients. Aliment Pharmacol Ther 24 (2006) 1349-1357
30. Muzzi A., Leandro G., Rubbia-Brandt L., et al. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 42 (2005) 41-46
31. D'Souza R., Sabin C.A., and Foster G.R. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 100 (2005) 1509-1515
32. Bugianesi E., Marchesini G., Gentilcore E., et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatology 44 (2006) 1648-1655
33. Kruszynska Y.T., Home P.D., and McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 14 (1991) 103-111
34. Pawlotsky J.M. Molecular diagnosis of viral hepatitis. Gastroenterology 122 (2002) 1554-1568
35. Bonora E., Targher G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23 (2000) 57-63
36. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
37. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24 (1996) 289-293
38. Strader D.B., Wright T., Thomas D.L., et al. Diagnosis, management and treatment of Hepatitis C. Hepatology 39 (2004) 1147-1171
39. Bauduceau B., Baigts F., Bordier L., et al. Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study). Diabetes Metab 31 (2005) 353-359
40. Bugianesi E., McCullough A.J., and Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42 (2005) 987-1000
41. Tilg H., and Hotamisligil G.S. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131 (2006) 934-945
42. Negro F. Insulin resistance and HCV. J Hepatol 45 (2006) 514-519
43. Romero-Gomez M. Insulin resistance and hepatitis C. World J Gastroenterol 12 (2006) 7075-7080
44. Aytug S., Reich D., Sapiro L.E., et al. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 38 (2003) 1384-1392
45. Shintani Y., Fujie H., Miyoshi H., et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126 (2004) 840-848
46. Walsh M.J., Jonsson J.R., Richardson M.M., et al. No-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signaling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut 55 (2006) 529-535
47. Harrison S.A. Correlation between insulin resistance and hepatitis C viral load. Hepatology 43 (2006) 1168
48. Sanyal A.J., Chand N., Comar K., et al. Hyperinsulinemia blocks the inhibition of hepatitis C virus (HCV) replication by interferon: a potential mechanism for failure of interferon therapy in subjects with HCV and nonalcoholic fatty liver disease. Hepatology 40 (2004) 179A
49. Kawaguchi T., Ide T., Taniguchi E., et al. Clearance of HCV improves insulin resistance, β-cell function, and hepatic expression of insulin receptor substrates 1 and 2. Am J Gastroenterol 102 (2007) 1-7
50. Paradis V., Perlemuter G., Bonvust F., et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34 (2001) 738-744
51. Ratziu V., Munteanu M., Charlotte F., et al. Fibrogenic impact of high serum glucose in chronic hepatitis C. J Hepatol 39 (2003) 1049-1055
52. Marcellin P., Asselah T., and Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 36 (2002) S47-S56
53. Ghany M.G., Kleiner D.E., Alter H., et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 124 (2003) 97-104
54. Asselah T., Bieche I., Laurendeau I., et al. Liver gene expression signature of mild fibrosis in chronic hepatitis C. Gastroenterology 129 (2005) 2064-2075
55. Adinolfi L.E., Gambardella M., Andreana A., et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients with specific HCV genotype and visceral obesity. Hepatology 33 (2001) 1358-1364
56. Patton H.M., Patel K., Behling C., et al. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol 40 (2004) 484-490
57. Fartoux L., Chazoullieres O., Wendum D., et al. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 41 (2005) 82-87
58. Asselah T., Boyer N., Guimont M.-C., et al. Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut 52 (2003) 1638-1643
59. Perumalswami P., Kleiner D.E., Lutchman G., et al. Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection. Hepatology 43 (2006) 780-787
60. Leandro G., Mangia A., Hui J., et al. Relationship between steatosis, inflammation and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 130 (2006) 1636-1642
61. Asselah T., Rubbia-Brandt L., Marcellin P., et al. Steatosis in chronic hepatitis C: what does it really matter?. Gut 55 (2006) 123-130
62. Romero-Gomez M., Viloria M., Andrade R., et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128 (2005) 636-641